'' Milestones ''1) For the first time ...Thank's to JTS in the next financials Genenews will have access to a fully functional billing process for an entire quarter.
2) For the first time ...Thank's to AIM Laboratories in the next financials Genenews will have access to a very big distribution network...
PressRelease Aug 15, 2018 Jame Tripp said (Quote) Cash receipts from our billings early in Q3 showing the increase we have been expecting, and incremental testing with High Risk populations as well as the ''AIM Reps beginning''(End of Quote).
Meaning: AIM Laboratories big distribution Sale Reps have begun to sell Genenews '' Holy-Grail'' cancer tests.
3) For the first time...Genenews has on board a Chief Commercial Officer. When a CCO come on board it is usually because sales and commercial operations are expected to grow significantly.
4) For the first time...Genenews has on board a very powerfull partner '' LifeX'', whose purpose is to promote visibility and sale of Genenews cancer tests. And to top it off LifeX CEO Dr Stephan is a Geneticist by profession (PHD Scientist).
You can't ask for somebody with better credentials than a PHD Geneticist to promote genenews '' Holy-Grail '' cancer tests.
It will be very interesting to see the impact of these ''First time Milestones '' on Genenews future financials.